From Lung Cancer to MCED: Clinical Applications Driving the Companion Diagnostics Market
The clinical applications of companion diagnostics span diverse oncology indications, from lung and breast cancer to emerging multi-cancer early detection. The Companion Diagnostics Market is benefiting from this diverse demand, valued at USD 9.32 billion in 2025 and projected to reach USD 26.83 billion by 2035 at a CAGR of 11.15%. This article explores the clinical applications...
0 Commentaires 0 Parts 3 Vue 0 Aperçu